TCL Archive Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research January 22, 1982
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000